PharVision Advisers’s Spotify SPOT Stock Holding History

PharVision Advisers’s Portfolio SPOT Stock Details SPOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-747	Closed	-$434K	–	572
2025 Q4	$434K	Buy	+747	New	+$467K	0.22%	89

Other funds holding SPOT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PharVision Advisers's SPOT Position: Q1 2026 in Review

PharVision Advisers sold out of Spotify (SPOT) in Q1 2026, closing a stake of 747 shares — an estimated $434K sold.

PharVision Advisers first reported a position in SPOT in Q4 2025 and held it in 1 quarter. The position peaked at $434K in Q4 2025. 1,273 funds tracked by Wall St. Rank hold SPOT as of Q1 2026.

PharVision Advisers reported no remaining Spotify position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 747 Spotify shares in Q1 2026, an estimated $434K.
PharVision Advisers first reported a position in Spotify in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Spotify position peaked at $434K in Q4 2025.
1,273 funds tracked by Wall St. Rank held Spotify as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.